FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016339719> ?p ?o ?g. }

• W2016339719 endingPage "394" @default.
• W2016339719 startingPage "389" @default.
• W2016339719 abstract "Summary An elevated erythrocyte arginase activity with a corresponding decrease in nitric oxide (NO) level has been implicated in the pathophysiology of sickle cell disease (SCD). Recent studies have shown that hydroxyurea (HU) increases the production of NO, which increases the soluble guanylate cyclase activity and fetal haemoglobin (HbF) synthesis. To study the effects of HU on the arginase and nitric oxide synthase (NOS) activities in SCD patients, we compared levels of arginase activity and NO metabolites in red blood cells and plasma, respectively, from 23 patients with SCD (HbSS) receiving HU therapy, with those of 12 SCD patients not receiving HU treatment. Patients on HU therapy showed significantly lower arginase activity than that of HbSS patients not on HU therapy (1·36 ± 0·2 U/10 8 cells vs. 3·31 ± 0·29 U/10 8 cells). NOS activity was higher in patients on HU therapy than in untreated patients (0·72 ± 0·4 nmol/ml/min vs. 0·35 ± 0·15 nmol/ml/min, P < 0·05). Among the HU‐treated patients, the decreased level of arginase activity correlated ( r = 0·71) with HbF level as well as the mean corpuscular haemoglobin content. These data suggest that one of the beneficial effects of HU in vivo may involve the regulation of arginase activity and a concomitant induction of NOS activity, which may lead to an increased production of NO. The outcome of this study may lead to the development of improved NO‐based treatments for SCD." @default.
• W2016339719 created "2016-06-24" @default.
• W2016339719 creator A5022152319 @default.
• W2016339719 creator A5042696665 @default.
• W2016339719 creator A5052634935 @default.
• W2016339719 creator A5056975396 @default.
• W2016339719 creator A5064853956 @default.
• W2016339719 creator A5068998171 @default.
• W2016339719 date "2005-10-17" @default.
• W2016339719 modified "2023-10-16" @default.
• W2016339719 title "Modulation of erythrocyte arginase activity in sickle cell disease patients during hydroxyurea therapy" @default.
• W2016339719 cites W1479457498 @default.
• W2016339719 cites W1532872507 @default.
• W2016339719 cites W1563516740 @default.
• W2016339719 cites W1973484838 @default.
• W2016339719 cites W1978444866 @default.
• W2016339719 cites W1996043889 @default.
• W2016339719 cites W1998006710 @default.
• W2016339719 cites W2007255960 @default.
• W2016339719 cites W2010469212 @default.
• W2016339719 cites W2012026140 @default.
• W2016339719 cites W2013392029 @default.
• W2016339719 cites W2022365217 @default.
• W2016339719 cites W2022705281 @default.
• W2016339719 cites W2042567177 @default.
• W2016339719 cites W2060238557 @default.
• W2016339719 cites W2061188498 @default.
• W2016339719 cites W2061561528 @default.
• W2016339719 cites W2101955568 @default.
• W2016339719 cites W2313541759 @default.
• W2016339719 cites W324137543 @default.
• W2016339719 cites W4249969224 @default.
• W2016339719 doi "https://doi.org/10.1111/j.1365-2141.2005.05772.x" @default.
• W2016339719 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16225659" @default.
• W2016339719 hasPublicationYear "2005" @default.
• W2016339719 type Work @default.
• W2016339719 sameAs 2016339719 @default.
• W2016339719 citedByCount "30" @default.
• W2016339719 countsByYear W20163397192012 @default.
• W2016339719 countsByYear W20163397192013 @default.
• W2016339719 countsByYear W20163397192015 @default.
• W2016339719 countsByYear W20163397192016 @default.
• W2016339719 countsByYear W20163397192020 @default.
• W2016339719 countsByYear W20163397192021 @default.
• W2016339719 countsByYear W20163397192022 @default.
• W2016339719 crossrefType "journal-article" @default.
• W2016339719 hasAuthorship W2016339719A5022152319 @default.
• W2016339719 hasAuthorship W2016339719A5042696665 @default.
• W2016339719 hasAuthorship W2016339719A5052634935 @default.
• W2016339719 hasAuthorship W2016339719A5056975396 @default.
• W2016339719 hasAuthorship W2016339719A5064853956 @default.
• W2016339719 hasAuthorship W2016339719A5068998171 @default.
• W2016339719 hasBestOaLocation W20163397191 @default.
• W2016339719 hasConcept C10162356 @default.
• W2016339719 hasConcept C126322002 @default.
• W2016339719 hasConcept C134018914 @default.
• W2016339719 hasConcept C150903083 @default.
• W2016339719 hasConcept C164007495 @default.
• W2016339719 hasConcept C172680121 @default.
• W2016339719 hasConcept C185592680 @default.
• W2016339719 hasConcept C207001950 @default.
• W2016339719 hasConcept C2776317666 @default.
• W2016339719 hasConcept C2777468819 @default.
• W2016339719 hasConcept C2777622882 @default.
• W2016339719 hasConcept C2778620579 @default.
• W2016339719 hasConcept C2779134260 @default.
• W2016339719 hasConcept C2779234561 @default.
• W2016339719 hasConcept C2779384505 @default.
• W2016339719 hasConcept C515207424 @default.
• W2016339719 hasConcept C519581460 @default.
• W2016339719 hasConcept C54355233 @default.
• W2016339719 hasConcept C55493867 @default.
• W2016339719 hasConcept C71924100 @default.
• W2016339719 hasConcept C86803240 @default.
• W2016339719 hasConceptScore W2016339719C10162356 @default.
• W2016339719 hasConceptScore W2016339719C126322002 @default.
• W2016339719 hasConceptScore W2016339719C134018914 @default.
• W2016339719 hasConceptScore W2016339719C150903083 @default.
• W2016339719 hasConceptScore W2016339719C164007495 @default.
• W2016339719 hasConceptScore W2016339719C172680121 @default.
• W2016339719 hasConceptScore W2016339719C185592680 @default.
• W2016339719 hasConceptScore W2016339719C207001950 @default.
• W2016339719 hasConceptScore W2016339719C2776317666 @default.
• W2016339719 hasConceptScore W2016339719C2777468819 @default.
• W2016339719 hasConceptScore W2016339719C2777622882 @default.
• W2016339719 hasConceptScore W2016339719C2778620579 @default.
• W2016339719 hasConceptScore W2016339719C2779134260 @default.
• W2016339719 hasConceptScore W2016339719C2779234561 @default.
• W2016339719 hasConceptScore W2016339719C2779384505 @default.
• W2016339719 hasConceptScore W2016339719C515207424 @default.
• W2016339719 hasConceptScore W2016339719C519581460 @default.
• W2016339719 hasConceptScore W2016339719C54355233 @default.
• W2016339719 hasConceptScore W2016339719C55493867 @default.
• W2016339719 hasConceptScore W2016339719C71924100 @default.
• W2016339719 hasConceptScore W2016339719C86803240 @default.
• W2016339719 hasIssue "3" @default.
• W2016339719 hasLocation W20163397191 @default.
• W2016339719 hasLocation W20163397192 @default.

• next